Ortospektras, UAB - financials and debts

Company age: 16 y. 7 mo.

Update

Ortospektras - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 94,856 93,768 77,942 91,240 91,124 90,862 75,746 59,205
Profit before tax - - - - - - - -
Net profit 22,848 16,143 10,077 19,358 15,873 14,886 9,895 664
Equity 94,412 111,416 120,631 139,989 155,862 171,515 180,621 181,285
Liabilities 43,946 15,877 11,762 14,098 11,600 6,287 3,124 9,963
Non-current assets 17,789 13,390 10,920 7,808 14,677 44,847 54,458 56,678
Current assets 120,063 113,451 120,959 145,899 152,219 132,338 128,673 133,983
Total assets 137,852 126,841 131,879 153,707 166,896 177,185 183,131 190,661
Taxes paid
STI taxes - - - - - 17,842 14,996 11,346
Financial indicators
Revenue change y/y +7.0% -1.1% -16.9% +17.1% -0.1% -0.3% -16.6% -21.8%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 16.6% 12.7% 7.6% 12.6% 9.5% 8.4% 5.4% 0.3%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 24.2% 14.5% 8.4% 13.8% 10.2% 8.7% 5.5% 0.4%
Profit margin Net profit margin. Shows the overall profitability of the company. 24.1% 17.2% 12.9% 21.2% 17.4% 16.4% 13.1% 1.1%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - - - - - - - -
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.5 0.1 0.1 0.1 0.1 0.0 0.0 0.1
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 47,428 46,884 38,971 45,620 45,562 45,431 37,873 29,603

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

Sales revenue

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Ortospektras - Social security debts

From To Debt, €
2025-08-31 2025-09-03 0.87
2025-08-19 2025-08-29 0.87
2025-07-24 2025-08-06 0.87
2025-06-17 2025-06-26 293.47
2023-07-26 2023-08-15 0.89
2023-07-24 2023-07-25 0.92
2023-06-16 2023-06-28 219.44
2023-05-02 2023-05-03 0.02
2023-04-25 2023-04-28 0.02
2023-03-16 2023-03-19 1.94
2023-02-17 2023-03-01 1.94
2023-02-06 2023-02-07 1.94
2023-01-23 2023-02-03 1.94
2023-01-17 2023-01-22 1.20
2022-12-16 2022-12-27 191.17
2022-11-21 2022-12-15 0.47
2022-11-17 2022-11-18 0.47
2022-10-28 2022-11-08 0.47
2022-09-16 2022-09-22 192.82
2022-08-23 2022-09-15 1.11
2021-11-16 2021-12-07 0.40
2021-11-09 2021-11-14 0.40

Ortospektras - VMI tax arrears

From To Overdue, €
2026-03-02 2026-03-02 428.1

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Ortospektras, UAB (code 302482616) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €59.2K and net profit of €664, corresponding to a profit margin of 1.1%. Performance has weakened over the last three years: revenue fell from €90.9K in 2023 to €75.7K in 2024 and then to €59.2K in 2025, while net profit declined from €14.9K to €9.9K and then to a near break-even result. The balance sheet remained conservative, with total assets increasing from €177.2K in 2023 to €183.1K in 2024 and €190.7K in 2025. Equity stayed broadly stable at €181.3K in 2025, while liabilities were low at €10.0K, supporting an equity ratio of 95.1% and a debt-to-equity ratio of 0.05. Asset turnover was 0.31x, ROE 0.4%, and ROA 0.3%. Revenue per employee was €29.6K, and profit per employee was €332.